NeuroIndex
EEG for Preventing Brain Injury During Anesthesia
Company Overview
Snapshot
Founded in April 2017, NeuroIndex was a startup with 1–10 employees. The company secured one funding round from one investor, Alon MedTech Ventures, in January 2020.
Business overview
NeuroIndex developed an AI-based brain health platform designed to prevent brain damage during anesthesia. Its core technology utilized EEG signals in response to sound stimuli, processed by a dedicated unit and monitored via a single-use headset. The platform aimed to identify real-time indications of brain damage during surgery, enabling anesthesiologists to intervene promptly and reduce post-operative neurocognitive disorders (PND). NeuroIndex operated within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Medical Monitors, serving the Healthcare market.
Company Intelligence Q&A
- What is NeuroIndex's primary focus?
- NeuroIndex focused on developing an AI-based brain health platform to prevent brain damage during anesthesia, utilizing EEG signals in response to sound stimuli.
- What was the status of NeuroIndex?
- NeuroIndex is non-active and ceased to operate in April 2022.
- When was NeuroIndex founded?
- NeuroIndex was founded in April 2017.
- What technology did NeuroIndex utilize?
- NeuroIndex's technology involved an AI-based platform that used a single-use headset for EEG monitoring and a processing unit to analyze brain signals.